SPATA7 antibody (C-Term)
Quick Overview for SPATA7 antibody (C-Term) (ABIN954913)
Target
See all SPATA7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 341-369, C-Term
-
Specificity
- This antibody recognizes SPATA7 / HSD3 at C-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 341-369aa) of human SPATA7 / HSD3
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SPATA7 (Spermatogenesis Associated 7 (SPATA7))
-
Alternative Name
- SPATA7 / HSD3
-
Background
- The SPATA7 gene, originally isolated from testis, is also expressed in retina. Mutations in this gene are associated with Leber's congenital amaurosis (LCA) and juvenile retinitis pigmentosa. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.Synonyms: HSD-3.1, Spermatogenesis-associated protein 7
-
Gene ID
- 55812
-
NCBI Accession
- NP_001035518
Target
-